Kelp for Health & Longevity - Quick Reference Sheet

Kelp for Health & Longevity

Created on 08/25/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 Audit

Kelp is the densest natural iodine source. It corrects a shortfall in people avoiding iodised salt, dairy, and seafood, and offers nothing to those who already have enough. Effects on blood sugar, cholesterol, and blood pressure are small. Excess iodine disturbs thyroid function in both directions and can worsen autoimmune thyroid disease. Products are often mislabelled and sometimes carry arsenic. (Full Review)

Protocol

Food-first standard
Kombu in stock or dried seaweed several times weekly
Kelp as food rather than a daily capsule, keeping iodine near habitual East Asian intake
Supplement dosing
150–300 µg iodine daily
Roughly 30–150 mg kelp powder depending on species and batch, or less for a concentrated extract
Best time of day
With a carbohydrate-containing meal
Applies where the aim is blunting post-meal glucose; timing is otherwise unimportant
Time to effect
Iodine status
Days
Urinary iodine responds within days; thyroid-stimulating hormone within two to four weeks
Glucose
Immediate
Meal-specific; split dosing across meals covers each carbohydrate load
Lipids and blood pressure
4–12 weeks
Retesting lipids before 8–12 weeks is uninformative

Benefits

Contraindications
  • Hashimoto's thyroiditis or other autoimmune thyroid disease with detectable thyroid peroxidase antibodies
  • Graves' disease, toxic multinodular goitre, or a hyperfunctioning thyroid nodule
  • Amiodarone, or antithyroid drugs (methimazole, carbimazole, propylthiouracil)
  • Awaiting radioactive iodine therapy or an iodinated-contrast study within four weeks
  • Pregnancy and breastfeeding
  • Chronic kidney disease at stage 4 or worse (estimated filtration rate below 30 mL/min/1.73 m²)
  • Documented iodine or seaweed hypersensitivity
Key Interactions
  • Levothyroxine and liothyronine (thyroid hormone replacement)
  • Warfarin and other vitamin K antagonists
  • Direct oral anticoagulants, heparins, and antiplatelet agents (apixaban, enoxaparin, aspirin, clopidogrel)
  • Potassium-sparing diuretics and ACE inhibitors (spironolactone, amiloride, lisinopril, ramipril)
  • Lithium
  • Iodine-containing supplements (potassium iodide, multivitamins, iodised salt, povidone-iodine antiseptics)
  • Selenium supplements
  • Bladderwrack, spirulina, chlorella, and other algal supplements

Risk & Side Effects

  • High: Iodine-induced thyroid dysfunction
  • Medium: Inorganic arsenic and toxic metal contamination; triggering or amplifying thyroid autoimmunity; elevated papillary thyroid carcinoma incidence with near-daily intake
  • Low: Gastrointestinal intolerance; anticoagulant activity of fucoidan-rich preparations
  • Speculative: Accelerated bone mineral loss; iodine-associated acneiform eruptions

Monitoring

Marker Target Why
Thyroid-stimulating hormone (TSH) 0.5–2.0 mIU/L Earliest and most sensitive signal of an iodine-driven thyroid shift
Free thyroxine (free T4) 1.0–1.5 ng/dL Confirms whether a thyroid-stimulating hormone change reflects real hormone loss
Free triiodothyronine (free T3) 3.0–4.0 pg/mL Reflects conversion to the active hormone, which iodine excess can suppress
Thyroid peroxidase antibodies Undetectable, below 9 IU/mL Identifies autoimmune thyroid disease, the group in whom kelp is contraindicated
Spot urinary iodine concentration 100–199 µg/L Direct measure of iodine status and of whether the dose is on target
Serum selenium 120–150 µg/L Determines whether the enzymes limiting iodine-driven oxidative injury are supported
Urinary total and speciated arsenic Total below 35 µg/g creatinine; inorganic and methylated forms below 15 µg/g Detects contamination from an uncertified product
Serum potassium 4.0–4.5 mmol/L Kelp adds potassium, which matters where kidney function is reduced
LDL cholesterol Below 100 mg/dL, lower where cardiovascular risk is elevated Tracks the lipid effect where cholesterol lowering is the intended target

Cadence: Baseline before starting; thyroid-stimulating hormone and free thyroxine at six to eight weeks, again at six months, then annually while intake continues. Urinary iodine rechecked at three months; urinary arsenic added at six months where the product lacks third-party contaminant certification.

Qualitative Assessment

  • Energy and exercise tolerance, which fall with thyroid underactivity and become erratic with overactivity
  • Cold or heat intolerance, a sensitive early subjective indicator of a thyroid shift in either direction
  • Resting heart rate and palpitations, which rise with excess thyroid hormone
  • Sleep quality and time to fall asleep
  • Bowel habit, which slows with underactivity and loosens with overactivity or with the fibre load itself
  • Skin, hair, and nail condition, including any new acne-like eruption
  • Neck fullness, swelling, or difficulty swallowing, suggesting goitre